Panpan Chen
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 16
- Autophagy in Disease and Therapy 8
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Haolin Chen (10 shared papers)Barry R. Zirkin (5 shared papers)Hui Jin (3 shared papers)Yuliang Zhao (2 shared papers)Miao Xu (1 shared paper)Yuzhu Ding (1 shared paper)Weidong Yin (1 shared paper)Minjie Li (2 shared papers)
- Journals
- Molecular and Cellular Endocrinology (4 papers)Blood (3 papers)Acta Pharmaceutica Sinica B (2 papers)Frontiers in Cell and Developmental Biology (2 papers)Frontiers in Plant Science (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Panpan Chen
95 papers receiving 1.8k citations
Panpan Chen's Hit Papers
Peers
Comparison fields: 5 of 125
- Geriatrics and Gerontology 93
- Infectious Diseases 377
- Health 118
- Reproductive Medicine 112
- Cancer Research 196
Countries citing papers authored by Panpan Chen
This map shows the geographic impact of Panpan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panpan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panpan Chen more than expected).
Fields of papers citing papers by Panpan Chen
This network shows the impact of papers produced by Panpan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panpan Chen. The network helps show where Panpan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Panpan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Hit paper breakdown → | 2021 | 364 |
| 2 | 2014 | 97 | |
| 3 | 2020 | 85 | |
| 4 | 2019 | 77 | |
| 5 | 2014 | 57 | |
| 6 | 2018 | 49 | |
| 7 | 2018 | 42 | |
| 8 | 2020 | 40 | |
| 9 | 2018 | 37 | |
| 10 | 2020 | 36 | |
| 11 | 2016 | 36 | |
| 12 | 2017 | 35 | |
| 13 | 2014 | 34 | |
| 14 | 2022 | 34 | |
| 15 | 2020 | 29 | |
| 16 | 2023 | 29 | |
| 17 | 2022 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2019 | 25 | |
| 20 | 2022 | 24 |
About Panpan Chen
Panpan Chen is a scholar working on Molecular Biology, Epidemiology, Oncology, Reproductive Medicine and Cancer Research, having authored 101 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sperm and Testicular Function (10 papers), Autophagy in Disease and Therapy (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (6 papers), CAR-T cell therapy research (6 papers), Cancer, Lipids, and Metabolism (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Testicular diseases and treatments (5 papers). The work is most often cited by research in Geriatrics and Gerontology (93 citations), Infectious Diseases (377 citations), Health (118 citations), Reproductive Medicine (112 citations) and Cancer Research (196 citations). Panpan Chen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Haolin Chen, Barry R. Zirkin, Hui Jin, Yuliang Zhao, Miao Xu, Yuzhu Ding, Weidong Yin, Minjie Li, Guoliang Cui and Wanqi Yang. Their work appears in journals such as Molecular and Cellular Endocrinology, Blood, Acta Pharmaceutica Sinica B, Frontiers in Cell and Developmental Biology and Frontiers in Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.